TormeyWPFitzgeraldRJ. The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid. Postgrad Med J1995; 71: 542–5.
2.
DeaconAC. The measurement of 5-hydroxyindoleacetic acid in urine. Ann Clin Biochem1994; 31: 215–32.
3.
KeatingJDratcuLLaderMSherwoodRA. Measurement of plasma serotonin by high performance liquid chromatography with electrochemical detection as an index of the in vivo activity of fluvoxamine. J Chrom Biomed Appl1993; 615: 237–42.
4.
ChallacombeDNDawkinsPDBakerP. Increased tissue concentration of 5-hydroxytryptamine in the duodenal mucosa of patients with coeliac disease. Gut1987; 18: 882–6.
5.
SjolundKNobinA. Increased levels of plasma 5-hydroxytryptamine in patients with coeliac disease. Scand J Gastroenterol1985; 20: 304–8.
6.
ChallacombeDNBrownGABlackSCStorrieMH. Increased excretion of 5-hydroxyindoleacetic acid in urine of children with untreated coeliac disease. Arch Dis Child1972; 47: 442–5.
7.
HeatonK. W.O'DonnellLJBraddonFEMMountfordRAHughesAOCrippsPJ. Symptoms of irritable bowel syndrome in a British urban community: Consulters and non-consulters. Gastroenterology1992; 102: 1962–7.
8.
ManningAPThompsonWGHeatonKWMorrisAF. Towards positive diagnosis of the irritable bowel. BMJ1978; 277: 653–4.
9.
O'FarrellyCMartenDMelcherDMcDougallBPriceRGoldsteinAJ. Villous atrophy in rheumatoid arthritis is associated with IgA RF and gliadin specific IgG. Lancet1988; ii: 819–22.
10.
BjarnasonIMacphersonAHollanderD. Intestinal permeability: An overview. Gastroenterology1995; 108: 1566–81.